LME approves Adani’s major copper smelter in India as listed brand

The London Metal Exchange has approved Adani Copper for delivery against its contracts, enabling warrant issuance from July 10. Produced by Adani Enterprises’ Kutch Copper unit in Gujarat, the facility has 500,000-tonne capacity. The move may boost India’s copper self-reliance and reduce import dependence amid steady domestic demand.

Temasek-backed Manipal Health gets SEBI approval for India IPO, eyes July listing

Manipal Health Enterprises, with the support of Singapore’s Temasek, has successfully obtained approval from SEBI for its initial public offering, set to take place in late July or early August. This ambitious hospital chain is targeting one of the largest IPOs in India’s healthcare landscape, aiming to raise as much as $1.2 billion, despite the current cautious market filled with geopolitical uncertainties and heavy foreign sell-offs.

Moneyview, Chandan Steel get Sebi’s approval for IPOs

The Securities and Exchange Board of India (Sebi) has granted approval for the Initial Public Offerings of fintech unicorn Moneyview and Chandan Steel. Moneyview strives to raise Rs 1,500 crore through a combination of fresh issues and offer for sale, aiming to enhance its financial services and loan disbursement operations. This milestone showcases a vibrant uptick in India’s IPO landscape, with Sebi’s approval being a vital step for both entities.

Rites among 5 stocks showing bullish RSI upswing

Five stocks in the Nifty500 segment that gained over 5% featured in the RSI Trending Up scan on July 1 after showing improving momentum. The RSI moved above the 50 mark from lower levels, signalling strengthening price action, improving sentiment and potential short-term buying opportunities for traders tracking bullish technical setups.

Advit Jewels IPO set for market debut today; GMP signals strong listing gains

Investor enthusiasm remains high ahead of the listing, with the company’s shares commanding a grey market premium (GMP) of around Rs 50, translating to nearly 36% above the upper issue price of Rs 138. Based on current GMP trends, the stock is expected to list at around Rs 188 per share, suggesting healthy listing gains for investors, although grey market premiums are unofficial and may not accurately predict the actual listing price.